25.03.2015 10:09:02
|
ZSPH Prices Offering At $46.25/Share
(RTTNews) - ZS Pharma Inc. (ZSPH) has now offered to sell 4.02 million shares of common stock to the public at a price of $46.25 each.
The offering, scheduled to close on March 30, 2015, is expected to rake in aggregate proceeds of $185.7 million. The company ended December 31, 2014 with cash of $102.3 million.
The company's lead drug candidate is ZS-9, which is being developed for the treatment of hyperkalemia, a potentially life-threatening condition characterized by abnormally high levels of potassium in the blood.
ZS Pharma expects to file the New Drug Application for ZS-9 with the FDA in the second quarter of 2015, and the Marketing Authorization Application for ZS-9 with the European Medicines Agency in the second half of 2015.
ZSPH closed Tuesday's trading at $46.59, down 0.13%.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ZS Pharma Incmehr Nachrichten
Keine Nachrichten verfügbar. |